Pharmafile Logo

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive meaningful change across the industry.

Traditionally, in the pharmaceutical industry, communication was driven by the sales representative. However, with an ever-changing technological world and the impact of the COVID-19 pandemic, which saw a decade of digital transformation happen overnight, HCPs have changed how they engage with various touchpoints, resulting in brands going back to the drawing board and experimenting with the optimal marketing mix. The reassessment of touchpoints has prompted brands to re-orchestrate how brand representatives are used, in some cases removing them completely, and trialling other more effective methods of reaching their audience.

As part of this new strategy, brands need access to in-depth and reliable data which provides crucial insights into the differences of HCPs and the touchpoints with which they engage. Point.1 was created to fulfil the void of data, which currently leaves brands making assumptions around HCP behaviour.

Point.1 generates data through proprietary research with the largest panel of healthcare professionals available. It is one of the most comprehensive uses of data in healthcare, covering 80 of the industry’s most relevant touchpoints, platforms, and journals – a 60% increase on what is currently available on the market.

Through Point.1, pharmaceutical companies and brands will have access to data that is actionable, consistent, and connected. It allows them to use data with purpose and perception to reach the right people, at the right time, and through the right channels.

Speaking about Point.1, Phil Streit, Global Head of Product Strategy, Havas Lynx Group, said: “In modern day advertising, data has become a valuable currency for brands, helping them to understand their customers better than ever before. However, while data is easily available on patients, the data available for healthcare professionals is practically non-existent.

“Point.1 was created to help brands understand the real-life differences and nuances of healthcare professionals. We like to think of the product in the terms of pixels. The more pixels you have, the clearer the picture and it’s the same when it comes to data. The more meaningful data you have, the better you understand HCPs. For example, through Point.1 we found that while 40% of boomer oncologists highly trust pharma sales reps, however only 23% of millennial oncologists trust them to the same level. So how do you reach that remaining 77%? Point.1 helps you to bridge that gap.”

Claire Knapp, CEO, Havas Lynx Group, said: “Historically, the pharmaceutical industry has struggled to acquire deep, granular, ex-US data. It has led to complexities for brands who are trying to make smart and efficient media and marketing decisions to reach the relevant healthcare professionals.

“Our goal with Point.1 is to bring more precise data with added context, to give brands the credibility and confidence in the insights and subsequent marketing decisions made. It will allow brands to be smarter and more effective, and to understand healthcare professionals, who are experiencing more burnout than ever before, and use data to drive an understanding that helps to deliver an impact.”

Point.1 was the proprietary data source of Havas Lynx Group’s latest thought leadership report ‘Healing the Healers’. The report investigates the vast deterioration of healthcare professional wellbeing and the critical impact on global healthcare systems. You can read the report here.

Havas Lynx Group has grown from a small creative agency formed in the Northern Quarter of Manchester into a global healthcare communications agency, offering campaign development, brand strategy, capability building, and education services.

This content was provided by Havas Lynx

Company Details

 Latest Content from  Havas Lynx 

03 Health Services

How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation

Havas Lynx shines a spotlight on carers

Manchester based healthcare communications agency, Havas lynx, has launched its annual white paper campaign, which this year promotes the vital need to support the growing number of carers in our...

SWITCHED ONcology. Healthcare Professionals Focus Group Highlights. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice...

SWITCHED ONcology. Healthcare Professional Experience Focus Group. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice...

SWITCHED ONcology. Caregivers Focus Group Full Discussion. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today's care continuum, the challenges they face and potential solutions...

SWITCHED ONcology. Caregivers Focus Group Highlights. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today's care continuum, the challenges they face and potential solutions...

SWITCHED ONcology Patient Experience Focus Group Full Discussion

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In...

SWITCHED ONcology Patient Experience Focus Group Highlights

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We...

SWITCHED ONcology

We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched...

18 SWITCHED ONcology: The Big Communication

Matching unprecedented clinical advances in immuno-oncology with transformative communication